Several lots of EpiPen, a leading emergency allergy treatment, are being recalled over a potential defect after two reports of the device failing to activate. The incidence of the defect is extremely rare and testing and analysis across the potentially impacted lots has not identified any units with a defect.
Patients will receive an EpiPen Auto-Injector at their pharmacy as a replacement based on product availability.
Mylan, the maker of the EpiPen, announced Friday that Meridian Medical Technologies expanded the recall to include the United States.
North Carolina Eligible to Be ACC Championship Host After Bathroom Law Repealed
RALEIGH, N.C. (AP) - Tense negotiations over a deal to undo North Carolina's "bathroom bill" gave way Friday to uncertainty. A recent Associated Press analysis suggested that the law cost North Carolina as much $3.76 billion in lost business .
EpiPen Jr (0.15 mg epinephrine) auto-injector lot 5GR765, expiry date March 2017. The company said more than 80,000 of the life-saving auto-injectors are covered by the recall worldwide, which was prompted by two reports of device failures.
Pfizer said it's committed to replacing the recalled devices at no cost and has advised consumers who have them to contact its information line at 1-800-463-6001. Patients, customers and distributors are being notified and should refer to Mylan.com/EpiPenRecall for updates on product return and replacement instructions. This company also makes a Generic EpiPen that is not included in the recall, according to ABC 15.
EpiPens deliver an emergency dose of adrenaline to people at risk of a serious allergic reaction.